Cytosorbents plans to add 3 to 5 Germany sales reps through early 2027 while targeting second-half 2026 operating cash flow breakeven

Positive

AI Analysis

Summary

Cytosorbents plans to hire 3 to 5 additional sales representatives in Germany through early 2027 and targets achieving operating cash flow breakeven in the second half of 2026.

Financial Highlights

Guidance

operating cash flow breakeven targeted for second-half 2026

Importance:2/10

Sentiment:

0.30

expansionsalesGermanycash flowguidance

Related Companies

$CTSO

Read the original article

Published by Seeking Alpha Healthcare on August 7, 2026 10:15 AM

Read Original